- Home
- REPL vs UHT Comparison
REPL vs UHT Comparison
Compare REPL & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- UHT
- Stock Information
- Founded
- REPL 2015
- UHT 1986
- Country
- REPL United States
- UHT United States
- Employees
- REPL N/A
- UHT N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- UHT Real Estate Investment Trusts
- Sector
- REPL Health Care
- UHT Real Estate
- Exchange
- REPL Nasdaq
- UHT Nasdaq
- Market Cap
- REPL 547.0M
- UHT 541.8M
- IPO Year
- REPL 2018
- UHT N/A
- Fundamental
- Price
- REPL $9.42
- UHT $40.32
- Analyst Decision
- REPL Buy
- UHT
- Analyst Count
- REPL 9
- UHT 0
- Target Price
- REPL $12.00
- UHT N/A
- AVG Volume (30 Days)
- REPL 2.6M
- UHT 84.6K
- Earning Date
- REPL 11-06-2025
- UHT 10-27-2025
- Dividend Yield
- REPL N/A
- UHT 7.46%
- EPS Growth
- REPL N/A
- UHT N/A
- EPS
- REPL N/A
- UHT 1.30
- Revenue
- REPL N/A
- UHT $100,898,000.00
- Revenue This Year
- REPL N/A
- UHT N/A
- Revenue Next Year
- REPL N/A
- UHT $0.81
- P/E Ratio
- REPL N/A
- UHT $31.17
- Revenue Growth
- REPL N/A
- UHT 1.00
- 52 Week Low
- REPL $2.68
- UHT $34.56
- 52 Week High
- REPL $17.00
- UHT $42.82
- Technical
- Relative Strength Index (RSI)
- REPL 62.38
- UHT 64.78
- Support Level
- REPL $8.50
- UHT $39.12
- Resistance Level
- REPL $9.30
- UHT $40.16
- Average True Range (ATR)
- REPL 0.61
- UHT 0.84
- MACD
- REPL -0.14
- UHT 0.18
- Stochastic Oscillator
- REPL 75.95
- UHT 98.52
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.